A new study detects breast cancer risk in pregnant women

A study realized by the Center of the Cancer Fox Chase in Philadelphia (United States) indicates that the women at high levels of inhibiting substance of Müllerian, known for regulating the sexual differentiation of the babies in the womb, might be under a major breast cancer risk.

The same one was presented in the magazine ‘Journal of the National Cancer Institute’ and he directed by the scientist Joanne F. Dorgan.

For such a conclusion there were studied 309 patients to whom him blood samples were extracted.
In parallel there were used blood samples donated by women with invasive or located breast cancer who at the moment of the donation were not enduring the illness. In the group of study, 105 women with breast cancer were paired by two women control.

The conclusion is that the concentrations in increase of inhibiting ustancia of Müllerian (SIM) were associated with a major breast cancer risk in the population.
The proper authors he thinks that it is still necessary to keep on investigating this way to be able to identify the biological mechanism that sublies to this association.